Continuing Medical Education (CME)

Online Courses

Title

HPV Vaccination: Make the Leap forward Now

Planning Committee

Dr. Marina Salvadori, MD, FRCPC
Dr. Eduardo L. Franco
Dr. Helene Gagne, MD

Course Dates

Beginning December 24, 2008 and ending December 23, 2009.

Learning Objectives

At the end of this course you should be able to:

Discuss the burden of HPV including cervical cancer, noncervical cancers, genital warts and other related lesions.
Differentiate the arguments in favor and against HPV vaccination and their supporting evidences
Identify WHO/FDA efficacy standards in HPV immunization
Describe the latest clinical data on HPV vaccines development programs in order to make a sound clinical decision
Review the outcomes of the 2007 Ontario HPV immunization program
Discuss the role and responsibility of the healthcare provider to recommend vaccination in their community according to guidelines and recommendation

Description

Worldwide approximately 500,000 women a year are diagnosed with invasive cervical cancer and approximately 250,000 die each year from the disease. Not surprisingly, invasive cervical cancer is highest in the developing world and in the underserved populations in developed countries.

Accreditation

This program meets the accreditation criteria of The College of Family Physicians of Canada and has been accredited for up to 1.0 MAINPRO-M1 credit.This event is an Accredited Group Learning Activity (Section 3) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada.

Cost

This case study is free to all physicians.

Supported by

Unrestricted educational grant received from Merck Frosst

Presented by

AdvancingIn

Specialty

Community Medicine, Family Medicine, Obstetrics, Gynecology

Last Updated April 20, 2009